Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Coronary Disease

1-methyl-3-isobutylxanthine has been researched along with Coronary Disease in 4 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research Excerpts

ExcerptRelevanceReference
"The aims of this study were to determine whether a relationship exists between the occurrence of coronary artery occlusion-induced arrhythmias in the anaesthetized rat and the levels of cyclic AMP and cyclic GMP in both normal and ischaemic myocardium, and to assess whether such arrhythmias were modified by pretreatment with the phosphodiesterase inhibitors, quazodine and isobutyl methylxanthine (IBMX), or with the butyryl derivatives of cyclic AMP and cyclic GMP."3.67The relationship between coronary artery occlusion-induced arrhythmias and myocardial cyclic nucleotide levels in the anaesthetized rat. ( Kane, KA; Morcillo-Sanchez, EJ; Parratt, JR; Rodger, IW; Shahid, M, 1985)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ross-Ascuitto, NT1
Ascuitto, RJ1
Ramage, D1
McDonough, KH1
Näbauer, M1
Böhm, M1
Brown, L1
Diet, F1
Eichhorn, M1
Kemkes, B1
Pieske, B1
Erdmann, E1
Holbrook, M1
Coker, SJ1
Kane, KA1
Morcillo-Sanchez, EJ1
Parratt, JR1
Rodger, IW1
Shahid, M1

Other Studies

4 other studies available for 1-methyl-3-isobutylxanthine and Coronary Disease

ArticleYear
The effects of milrinone in the neonatal pig heart.
    Cardiovascular drugs and therapy, 1991, Volume: 5, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Animals, Newborn; Cells, Cultured; Coronary Circulation; Coron

1991
Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts.
    European journal of clinical investigation, 1988, Volume: 18, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; Adult; Bucladesine; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agent

1988
Comparison of the effects of isobutylmethylxanthine and milrinone on ischaemia-induced arrhythmias and platelet aggregation in anaesthetized rabbits.
    British journal of pharmacology, 1989, Volume: 98, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bloo

1989
The relationship between coronary artery occlusion-induced arrhythmias and myocardial cyclic nucleotide levels in the anaesthetized rat.
    British journal of pharmacology, 1985, Volume: 84, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Anesthesia; Animals; Arrhythmias, Cardiac; Bucladesine; Coronary Diseas

1985